Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

OTC Markets Group is undervalued with strong customer dependency and earnings growth. Read why OTCM stock is a solid pick due to its competitive advantage.

The outflow of gold stored in the London vaults to the United States slowed in February, the London Bullion Market ...

OTC Markets Group Inc. (OTCM) came out with quarterly earnings of $0.60 per share, missing the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.58 per share a year ago.

OTC Markets Group announced today that its Board of Directors authorized and approved a quarterly cash dividend of $0.18 per share of Class A Common Stock. The quarterly cash dividend is payable on ...

Glenmark Pharmaceuticals launches polyethylene glycol 3350, a constipation treatment medicine in the US. The OTC product aims ...

US leads multiyear record inflows February in review. Global physically backed gold ETFs 1 saw significant inflows in ...

As the future of UK and European capital markets remains uncertain and the debate on London and European markets versus New ...

According to Nielsen® syndicated data for the latest 52 weeks' period ending February 22, 2025, the MiraLAX® Powder for Solution, 17 grams (OTC) market 3 achieved annual sales of approximately $ ...

Glenmark Pharmaceuticals has introduced a new constipation treatment, polyethylene glycol 3350 powder, to the US market. This launch aims to fulfill the rising demand for a fresh supplier in the ...

MAHWAH, N.J., March 10, 2025 /PRNewswire/ -- Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC ...